Search COVID-19 Rapid Resource Center or explore resources sorted by Category or Content Type.
Placenta-Derived Cell Therapy to Treat Patients With Respiratory Failure Due to Coronavirus Disease 2019
From Critical Care Explorations
The authors sought to determinewhether placental cell therapy PLacental eXpanded (PLX)-PAD (Pluristem Therapeutics, Haifa, Israel) was beneficial to treating critically ill patients suffering from acute respiratory distress syndrome due to coronavirus disease 2019.
Authors:
Barkama R, Mayo A, Paz A, et al.
Estimated Time: 24:18
Categories:
Crisis Management, Hematology,
Content Type:
Articles,